Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2014-000882-34-BE
EUCTR2014-000882-34-BE
Active, not recruiting
Phase 1

Catheter based adjuvant intraperitoneal chemotherapy for carcinomatosis.

niversity Hospital Ghent0 sites24 target enrollmentMay 5, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionscarcinomatosisMedDRA version: 17.0Level: LLTClassification code 10007506Term: CarcinomatosisSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
DrugsFluracedyl 50 mg/ml, oplossing voor injectie

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
carcinomatosis
Sponsor
niversity Hospital Ghent
Enrollment
24
Status
Active, not recruiting
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 5, 2014
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity Hospital Ghent

Eligibility Criteria

Inclusion Criteria

  • •\-Peritoneal carcinomatosis from GI origin (appendix, colon, small bowel, stomach)
  • •\-Resectable disease
  • •\-No or minimal systemic or extra\-abdominal disease or metastatic spread
  • •\-Written informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 22
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 2

Exclusion Criteria

  • •\-Comorbidity that precludes surgery and/or IP chemotherapy
  • •\-Irresectable disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Preoperative intraperitoneal chemotherapy in adjuvant hyperthermiaadjunctive therapy in advanced gastric cancer with high-risk of peritoneal recurrence - a multicentre randomized trialGastric CarcinomaMedDRA version: 21.0Level: LLTClassification code 10007350Term: Carcinoma gastricSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2020-001419-25-PLJagiellonian University Medical College600
Active, not recruiting
Not Applicable
Intraperitoneal hyperterm chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal origiAdjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosisthe COLOPEC randomized multicenter trialTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2014-002794-11-NLAcademic Medical Center176
Completed
Phase 3
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicenter trial.metastases of peritoneumperitoneal carcinomatosis100179901002747610017998
NL-OMON47140Academisch Medisch Centrum185
Not yet recruiting
Phase 2
Determining the efficacy and safety of neoadjuvant IP chemotherapy in rectal cancer patients with the spread of disease in peritoneumHealth Condition 1: C20- Malignant neoplasm of rectum
CTRI/2023/11/059575Tata Memorial Hospital
Active, not recruiting
Phase 1
Intraoperatieve intraperitoneale Chemoperfusie voor de behandeling van minimale residuele ziekte bij stadium III Eierstokkanker: een gerandomiseerde fase II studie.stage III ovarian cancerTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2015-000418-23-BEGhent University Hospital60